Drug Approval | September 30, 2022
USFDA inspects Zydus Lifesciences Ahmedabad SEZ facility
The company will address the observations within a stipulated timeline working with the regulators
The company will address the observations within a stipulated timeline working with the regulators
New Regional Processing Lab will serve Ahmedabad and the state of Gujarat
The transplant procedure was completed in under two hours
Ibrutinib tablets will be produced at Zydus Lifesciences Ltd (SEZ), Ahmedabad
Celecoxib is a nonsteroidal anti-inflammatory drug
Emcure Pharmaceuticals successfully completes USFDA PAI of Oncology facility
Rifaximin tablets had annual sales of US$ 2672.9 mn in the United States (IQVIA MAT March 2025)
Isotretinoin capsules are indicated to treat severe, disfiguring nodular acne
Niacin is indicated to reduce elevated total cholesterol, LDL cholesterol, apolipoprotein B and triglycerides (TG)
Apalutamide is an androgen receptor inhibitor indicated for the treatment of patients with metastatic castration-sensitive prostate cancer
Subscribe To Our Newsletter & Stay Updated
